Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
11/2009
11/19/2009US20090286806 Isoxazole derivatives as calcium channel blockers
11/19/2009US20090286793 Pde4b inhibitors and uses therefor
11/19/2009US20090286791 Amide Compounds
11/19/2009US20090286790 Organic compounds
11/19/2009US20090286787 Substituted gamma lactams as therapeutic agents
11/19/2009US20090286786 Compounds having a 4-pyridylalkylthio group as a substituent
11/19/2009US20090286785 Pyrimidine Derivatives
11/19/2009US20090286784 Indazole, benzisoxazole, and benzisothiazole kinase inhibitors
11/19/2009US20090286783 Pyrrolo(2,3-d)pyrimidine kinase inhibitors; melanoma, colorectal cancer, pain, polycystic kidney disease and other Raf protein kinase related conditions; e.g. Propane-1-sulfonic acid[3-(4-cyclopropyl-7H-pyrrolo[2,3-d]pyrimidine-5-carbonyl)-2,4-difluoro-phenyl]-amide; Raf kinases including B-raf, A-raf
11/19/2009US20090286780 2-oxochromene derivatives
11/19/2009US20090286779 Pyrazolopyrimidines as lipid kinase inhibitors
11/19/2009US20090286772 2-(Phenyl or Heterocyclic)-1H-Phenanthro[9,10-D]Imidazoles
11/19/2009US20090286767 Substituted quinolin-4-ylamine analogues
11/19/2009US20090286766 Azolecarboxamide derivative
11/19/2009US20090286765 Therapeutic Agents
11/19/2009US20090285849 Thiosemicarbazones as anti-virals and immunopotentiators
11/19/2009US20090285782 4,6-di- and 2,4,6-trisubstituted quinazoline derivatives useful for treating viral infections
11/19/2009CA2724232A1 Sulfone compounds which modulate the cb2 receptor
11/19/2009CA2724077A1 Amide compound
11/19/2009CA2724055A1 Glucocorticoid receptor agonist comprising 2,2,4-trimethyl-6-phenyl-1,2 -dihydroquinoline derivatives having substituted oxy group
11/18/2009EP2119715A1 Benzimidazole derivative and its use as aii receptor antagonist
11/18/2009EP2119703A1 Novel indole derivative having inhibitory activity on i b kinase
11/18/2009EP2118093A1 [1,2,3]triazolyl substituted quinolines and coumarins as inhibitors of leukotriene biosynthesis
11/18/2009EP2118087A1 Pi 3-kinase inhibitors and methods of their use
11/18/2009EP2118074A1 Compounds for the prevention and treatment of cardiovascular diseases
11/18/2009EP2118067A1 Nicotinic acetylcholine receptor modulators
11/18/2009EP2117541A1 Compounds and compositions as channel activating protease inhibitors
11/18/2009EP2117311A1 Therapeutic agents
11/18/2009EP1888538B1 (3,4-dihydro-quinazolin-2-yl)-(2-aryloxy-ethyl)-amines having an activity on the 5-ht receptor
11/18/2009EP1597229B1 Pyrrolidine derivatives as oxytocin antagonists
11/18/2009EP1490064B1 Substituted pyridinones as modulators of p38 map kinase
11/18/2009EP1442026B9 Triazole derivatives as cyclooxygenase (cox) inhibitors
11/18/2009EP1421071B1 Substituted piperazine and diazepane derivaives as histamine h3 receptor modulators
11/18/2009EP1218354B1 Quinazoline derivatives and their use as pharmaceuticals
11/18/2009EP0760811B1 Imidazole derivatives as histamine receptor h3 modulators
11/18/2009CN101583606A Compounds and methods for inhibiting the interaction of BCL proteins with binding partners
11/18/2009CN101580504A Organic compound, benzoxazole derivative, and light-emitting element using the benzoxazole derivative
11/18/2009CN101580497A Statins antilipemic drugs furazan nitroxides derivates and preparation method thereof
11/18/2009CN100560584C Benzoazolypiperazine derivatives having MGLUR1- and MGLUR5-antagonistic activity
11/18/2009CN100560566C Benzyloxy derivatives as MAOB inhibitors
11/17/2009US7618978 Amides as BACE inhibitors
11/17/2009US7618975 4-arylamino-quinazolines and analogs as activators of caspases and inducers of apoptosis; antiproliferative, anticarcinogenic, antimetabolic agents; tubulin and topoisomerase II inhibitors; fungicides; synergistic administration with other anticarcinogenic agents
11/17/2009US7618965 (Arylamidoanilino)nitroethylene compounds
11/17/2009US7618964 Benzamide derivatives, their manufacture and use as pharmaceutical agents
11/17/2009US7618961 A sulfonylamino-tetrahydro(1,3)thiazolo(5,4-c)pyridinyl or benzothiazole derivatives, for treating diabetes, syndrome X, obesity, glaucoma, hyperlipidemia, hyperglycemia, hyperinsulinemia, osteoporosis, tuberculosis, dementia
11/17/2009US7618959 6-({2-[4-(6-Methoxy-[1,5]naphthyridin-4-yl)phenyl]ethylamino}methyl)-4H-pyrido[3,2-b][1,4]thiazin-3-one;bacterial infections; antibiotic resistance; Staphylococcus aureus, Streptococcus pneumoniae and pyogenes, Enterococcus; Haemophilus influenzae, Moraxella catarrhalis, E-coli
11/17/2009CA2521950C Benzoxazinyl-amidocyclopentyl-heterocyclic modulators of chemokine receptors
11/17/2009CA2450801C Drugs that enhance synaptic responses mediated by ampa receptors
11/17/2009CA2444501C Phenylindoles for the treatment of hiv
11/17/2009CA2441239C Mch antagonists and their use in the treatment of obesity
11/17/2009CA2382296C Selective cox-2 inhibitory novel esters from indolealkanols and novel amides from indolealkylamines
11/17/2009CA2374158C Indole derivatives
11/17/2009CA2352494C Compositions and methods for the treatment of alzheimer's disease, central nervous system injury, and inflammatory diseases
11/17/2009CA2321198C 2-arylethyl-(piperidin-4-ylmethyl)amine derivatives as muscarinic receptor antagonists
11/17/2009CA2272460C Pyridin-2-yl-methylamine derivatives, method of preparing and application as medicine
11/12/2009WO2009137429A1 Method of treating cancer using a cmet and axl inhibitor and an erbb inhibitor
11/12/2009WO2009137412A1 Therapeutic compounds
11/12/2009WO2009137411A1 Therapeutic compounds
11/12/2009WO2009137404A1 Urea compounds as gamma secretase modulators
11/12/2009WO2009137251A2 Cysteine and cystine bioisosteres to treat schizophrenia and reduce drug cravings
11/12/2009WO2009137081A2 Small molecule inhibitors of plasmodium falciparum dihydroorotate dehydrogenase
11/12/2009WO2009136995A2 Inhibitors of syk protein kinase
11/12/2009WO2009136850A1 Muscarinic receptor agonits useful in the treatment of pain, alzheimer's disease and schizophrenia
11/12/2009WO2009136175A1 Compounds for use in stabilizing p53 mutants
11/12/2009WO2009135299A1 3, 4 - substituted piperidine derivatives as renin inhibitors
11/12/2009WO2009117467A3 Therapeutic compounds
11/12/2009WO2009115874A3 Novel heterocyclic compounds, pharmaceutical compositions containing them and processes for their preparation
11/12/2009WO2009080250A3 Insecticidal compounds
11/12/2009WO2009018807A9 Oxazolidinones as factor xa inhibitors, methods for the production thereof, and use thereof in therapy
11/12/2009WO2008133344A3 Piperidine derivative and use thereof
11/12/2009WO2007084435A8 Methods for treating hepatitis c
11/12/2009US20090281336 Benzofuran compounds, compositions and methods for treatment and prophylaxis of hepatitis c viral infections and associated diseases
11/12/2009US20090281310 Cinnamide compound
11/12/2009US20090281308 Chemokine receptor binding heterocyclic compounds with enhanced efficacy
11/12/2009US20090281215 Polytriazinyl Compounds as Flame Retardants and Light Stabilizers
11/12/2009US20090281176 Process for the synthesis of ramelteon and its intermediates
11/12/2009US20090281152 Indole Compounds Having Affinity to the EP1 Receptor
11/12/2009US20090281102 Therapeutic n-aryl or n-heteroaryl pyrazolidine and pyrazolidinone derivatives
11/12/2009US20090281101 5-(3-(3-(4-hexanoylphenyl)-2,5-dioxoimidazolidin-4-yl)propyl)thiophene-2-carboxylic acid; prostaglandin agonist; ocular hypotensive agent; post-sergical and post-laser trabeculectomy ocular hypertensive episodes, glaucoma, and as presurgical adjuncts
11/12/2009US20090281100 Benzimidazole quinolinones and uses thereof
11/12/2009US20090281099 Substituted pyrazinone derivatives for use as a medicine
11/12/2009US20090281098 Benzoimidazole compound capable of inhibiting prostaglandin d synthetase
11/12/2009US20090281097 Nitrogen-containing heterocyclic compound
11/12/2009US20090281096 Cyclothiocarbamate derivatives as progesterone receptor modulators
11/12/2009US20090281089 Pyridyl inhibitors of hedgehog signalling
11/12/2009US20090281081 Chemokine receptor antagonists and methods of use therefor
11/12/2009US20090281076 Azetidine Derivatives as G-Protein Coupled Receptor (GPR119) Agonists
11/12/2009US20090281075 Isomeric purinones and 1h-imidazopyridinones as pkc-theta inhibitors
11/12/2009US20090281072 Diaminopyrimidinecarboxamide Derivative
11/12/2009US20090281069 Organic compounds
11/12/2009US20090281060 Heterocyclic derivatives as gpcr receptor agonists
11/12/2009US20090281053 Novel crystalline form of lamivudine
11/12/2009US20090280555 Enzyme treatment of foodstuffs for celiac sprue
11/12/2009CA2728893A1 Inhibitors of syk protein kinase
11/12/2009CA2723699A1 Method of treating cancer using a cmet and axl inhibitor and an erbb inhibitor
11/12/2009CA2723679A1 Muscarinic receptor agonists useful in the treatment of pain, alzheimer's disease and schizophrenia
11/12/2009CA2722734A1 3,4-substituted piperidine derivatives as renin inhibitors
11/12/2009CA2722606A1 Urea compounds as gamma secretase modulators
11/12/2009CA2721433A1 Cysteine and cystine bioisosteres to treat schizophrenia and reduce drug cravings
11/11/2009EP2116541A1 Proline derivatives and their use as dipeptidyl peptidase IV inhibitors
1 ... 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 ... 647